Score Your Stock

TMCLIFE TMC LIFE SCIENCES BERHAD

0101.KL · Health Care · Health Care Providers
Top 38% of scored stocks
Compare with nearby peers
OkayTop 38% of scored stocksLast year (FY2025): 41
Shariah

TMCLIFE scores 57/100 on fundamentals: in the top 38% of 1120 scored Bursa Malaysia stocks. Its strongest area is Financial Safety (83/100); its weakest is Price Fairness (33/100).

Best
Financial 83
Weakest
Price 33
Mkt capRM 714.2m#239 of 1113 in BursaEPSRM 0.01P/E41.1×✗ vs sector avg 25.6×P/B0.8×✓ vs sector avg 1.8×Div yield0%✓ Top 50% in Bursa52w range · 6% of range0.400.57
as of 18 Oct 2026

Nearby peers

Ranks #11 of 30 in Health Care by score

#1DPHARMA85#9TOPGLOV58#10SCOMNET57
#11TMCLIFE57
#12KOTRA53#13METRO53

One-Minute Summary

Why TMCLIFE scores 57

A financially strong, expensively priced stock, but price fairness needs attention.

What looks good
What to watch

After Jun '26 results: 47 → 47See all movers →

Business Strength

40
Why 40?
Pillar score: (0 + 2 + 0 + 0 + 2) = 4 of 10 points → 40
Return on Equity (ROE)2%Weak4-Year Revenue Growth+8%/yrStrong4-Year Profit Growth-24%/yrWeakNet Profit Margin4%WeakQuarterly Momentum+14%Strong
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↓ -55.7%Equity → +0.6%ROE % 2%
Net ProfitEquityROE %
39m41m4m17m862m888m853m867m20232024202520264.6%4.6%0.4%2%

Revenue & Net Profit, with Net Margin

Revenue ↑ +26.2%Net Profit ↓ -55.7%Net Margin % 4.4%
RevenueNet ProfitNet Margin %
311m346m346m393m39m41m4m17m202320242025202612.6%11.7%1%4.4%

Sales grew about 26.2% over 4 years: customers keep spending more with this company.

Profit fell about 55.7% from where it was 4 years ago: the boom has cooled off.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +21.2%Net Profit ↑ +58.6%Net Margin % 4.6%
RevenueNet ProfitNet Margin %
82m80m90m93m101m104m90m99m3m-1m-1m2m4m7m2m5mSep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '263.5%-1.1%-0.9%2.6%4.4%6.4%2%4.6%
▼▼▼▲▲▲▲▲

Sales grew about 21.2% over the last 8 quarters: customers keep spending more with this company.

The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.

Why 83?
Pillar score: (2 + 2 + 1) = 5 of 6 points → 83
Debt-to-Equity0.2×StrongCurrent Ratio1.7×StrongInterest Coverage4.4×Okay
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↓ -33.7%Equity → +0.6%D/E 0.2×
Total DebtEquityD/E
219m205m183m145m862m888m853m867m20232024202520260.3×0.2×0.2×0.2×

Borrowings fell about 33.7% over 4 years: the company is steadily getting safer.

Short-term assets vs bills, with Current Ratio

Current Assets ↓ -21.6%Current Liabilities ↑ +18.6%Current Ratio 1.7×
Current AssetsCurrent LiabilitiesCurrent Ratio
252m263m203m197m99m99m110m117m20232024202520262.6×2.7×1.8×1.7×
Why 50?
Pillar score: (0 + 1 + 2 + 1) = 4 of 8 points → 50
Dividend Quality0%Weak
Payout ratio: 19%
Operating Cash FlowPositive but bumpyOkayFree Cash FlowPositive & growingStrongCash & Cash EquivalentsPartly healthyOkay
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↑ +5.7%Free CF ↑ +113.4%
Operating CFFree CF
55m75m23m58m20m46m-19m43m2023202420252026

Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.

Cash vs Total Debt

Cash ↓ -33.5%Short-Term Debt ↑ +198.7%Total Debt ↓ -33.7%
CashShort-Term DebtTotal Debt
162m184m106m108m15m23m38m45m219m205m183m145m2023202420252026

Dividends per Share, with Yield

DPS (sen) ↓ -32.1%Yield % 0.4%
DPS (sen)Yield %
0.30.82.20.220222023202420250.5%1.5%3.7%0.4%

Dividends were cut during this period: payouts here are not guaranteed pocket money.

Why 33?
Pillar score: (0 + 2 + 0) = 2 of 6 points → 33
P/E Ratio41.1×WeakP/B Ratio0.8×StrongPEG Ration/m (growth not measurable)Weak
Show chart

Score vs Share Price

Score (0-100)Share price
RM 0.56RM 0.48RM 0.41100500score 41 → 57Oct '25Feb '26Jun '26Oct '26💰📊📊

The share price is down about 6.4% over the past year.

What happened, and how the price moved

Why 75?
Pillar score: (2 + 2 + 2 + 1 + 2 + 0) = 9 of 12 points → 75
Earnings ConsistencySteadyStrongDebt Trend (4yr)FallingStrongShare Count Trend (4yr)+0%/yrStrongInventory vs Sales (4yr)+7.3 pp/yr vs salesOkayAsset Turnover Trend (4yr)+33.2%StrongQuarterly ConsistencyLoss in 2 of 8 quartersWeak
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +26.2%Inventory ↑ +53%Inv. % of Rev. 5.2%
RevenueInventoryInv. % of Rev.
311m346m346m393m13m12m16m21m20232024202520264.3%3.3%4.6%5.2%

Get an email when TMCLIFE's score changes, and why

Own more than one stock? Check them all at once ›
Ranks #11 of 30 in Health Care by score

Sector peers

#1DPHARMA85#9TOPGLOV58#10SCOMNET57
#11TMCLIFE (you)57
#12KOTRA53#13METRO53

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDividend Payout RatioDiv yieldP/E RatioP/B Ratio
2026RM 393.0mRM 17.4mRM 57.7mRM 42.9mRM -14.7mRM 108.0mRM 145.2mRM 45.1mRM 867.2mRM 197.3mRM 116.9mRM 1.1bRM 247.9mRM 20.5m-2%4%0.2×1.7×4.4×19%0%45.1×0.9×
2025RM 345.5mRM 3.6mRM 22.5mRM -18.6mRM -41.1mRM 105.5mRM 183.0mRM 37.6mRM 853.0mRM 202.5mRM 110.3mRM 1.1bRM 279.1mRM 15.9mRM 0.2m0%1%0.2×1.8×1.8×1071%0%209.2×0.9×
2024RM 346.4mRM 40.6mRM 74.8mRM 46.2mRM -28.5mRM 184.4mRM 205.2mRM 22.6mRM 888.0mRM 262.5mRM 98.6mRM 1.2bRM 301.7mRM 11.6mRM 2.2m5%12%0.2×2.7×6.1×36%4%27.0×1.2×
2023RM 311.4mRM 39.3mRM 54.6mRM 20.1mRM -34.5mRM 162.4mRM 219.1mRM 15.1mRM 862.0mRM 251.8mRM 98.6mRM 1.2bRM 314.8mRM 13.4mRM 0.8m5%13%0.3×2.6×5.4×12%1%25.1×1.1×